Search

Your search keyword '"Ben Salah, Afif"' showing total 210 results
Start Over Author "Ben Salah, Afif"
210 results on '"Ben Salah, Afif"'

1. Healthcare personnel acceptance and recommendations for influenza vaccine in twelve low- and middle-income countries: A pooled analysis from 2018 to 2020

Author

McCarron, Margaret, Marcenac, Perrine, Yau, Tat S., Lafond, Kathryn E., Ebama, Malembe S, Duca, Lindsey M., Sahakyan, Gayane, Bino, Silvia, Coulibaly, Daouda, Emukule, Gideon, Khanthamaly, Vieng, Zaraket, Hassan, Cherkaoui, Imad, Otorbaeva, Dinagul, Stravidis, Kristina, Safarov, Abdulakhad, Bettaieb, Jihene, Igboh, Ledor S., Azziz-Baumgartner, Eduardo, Vanyan, Artavazd, Manukyan, Ani, Nelaj, Erida, Preza, Iria, Douba, Alfred, N'Gattia, Anderson, Tengbriacheu, Chankham, Pathammavong, Chansay, Alame, Malak, Alj, Loubna, Ben Salah, Afif, Lambach, Philipp, and Bresee, Joseph S.

Published
2024
Full Text
View/download PDF

2. Influenza vaccine uptake and its determinants among adult population in the Kingdom of Bahrain: a cross-sectional study to identify areas for intervention

Author

Alzayani, Salman, primary, Al Sedran, Mohammed, additional, Aburowais, Safa, additional, Hammad, Jumana, additional, Almuaili, Noora, additional, Alkawari, Shaikha, additional, Bureshaid, Rayan, additional, Almalki, Muhannad, additional, Almarabheh, Amer, additional, and Ben Salah, Afif, additional

Published
2023
Full Text
View/download PDF

11. Epidemiology and burden of Severe Acute Respiratory Infections (SARI) in the aftermath of COVID-19 pandemic: A prospective sentinel surveillance study in a Tunisian Medical ICU, 2022/2023.

Author

Boussarsar, Mohamed, Ennouri, Emna, Habbachi, Naima, Bouguezzi, Nabil, Meddeb, Khaoula, Gallas, Salma, Hafdhi, Malek, Zghidi, Marwa, Toumi, Radhouane, Ben Saida, Imen, Abid, Salma, Boutiba-Ben Boubaker, Ilhem, Maazaoui, Latifa, El Ghord, Hakim, Gzara, Ahlem, Yazidi, Rihab, and Ben Salah, Afif

Subjects
RESPIRATORY infections, COVID-19 pandemic, SARIS, EPIDEMIOLOGY, RESOURCE mobilization, COVID-19
Abstract

Background: Severe Acute Respiratory Infections (SARI) caused by influenza and other respiratory viruses pose significant global health challenges, and the COVID-19 pandemic has further strained healthcare systems. As the focus shifts from the pandemic to other respiratory infections, assessing the epidemiology and burden of SARI is crucial for healthcare planning and resource allocation. Aim: to understand the impact of the post-pandemic period on the epidemiology of SARI cases, clinical outcomes, and healthcare resource utilization in Tunisia. Methods: This is a prospective study conducted in a Tunisian MICU part of a national sentinel surveillance system, focusing on enhanced SARI surveillance. SARI cases from week 39/2022, 26 September to week 19/2023, 13 May were included, according to a standardized case definition. Samples were collected for virological RT-PCR testing, and an electronic system ensured standardized and accurate data collection. Descriptive statistics were performed to assess epidemiology, trends, and outcomes of SARI cases, and univariate/multivariate analyses to assess factors associated with mortality. Results: Among 312 MICU patients, 164 SARI cases were identified during the study period. 64(39%) RT-PCR were returned positive for at least one pathogen, with influenza A and B strains accounting for 20.7% of cases at the early stages of the influenza season. The MICU experienced a significant peak in admissions during weeks 1-11/2023, leading to resource mobilization and the creation of a surge unit. SARI cases utilized 1664/3120 of the MICU-stay days and required 1157 mechanical ventilation days. The overall mortality rate among SARI cases was 22.6%. Age, non-COPD, and ARDS were identified as independent predictors of mortality. Conclusions: The present study identified a relatively high rate of SARI cases, with 39% positivity for at least one respiratory virus, with influenza A and B strains occurring predominantly during the early stages of the influenza season. The findings shed light on the considerable resource utilization and mortality associated with these infections, underscoring the urgency for proactive management and efficient resource allocation strategies. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

12. Comparison of the clinical features and outcomes of severe seasonal influenza and COVID‐19 patients in Tunisia between 2021 and 2022.

Author

Ben Khelil, Jalila, Yazidi, Rihab, Ben Mrad, Nacef, Jarraya, Fatma, Rachdi, Emna, Ayed, Samia, Jamoussi, Amira, Ben Salah, Afif, and Besbes, Mohamed

Subjects
SEASONAL influenza, COVID-19, RESPIRATORY infections, MEDICAL care, INTENSIVE care units
Abstract

Background: We compared patients diagnosed at a SARI (severe acute respiratory infections) surveillance site with COVID‐19 and those with seasonal influenza to investigate the clinical differences, common features, and outcomes. Methods: We conducted a descriptive, retrospective study in the Medical Intensive Care Unit (ICU) at Abderrahman Mami Hospital between September 2021 and April 2022. Demographic, clinical, and biological data as well as outcomes were recorded for all patients. Results: Among 223 SARI patients, 83 were confirmed COVID‐19, and 22 were influenza positive. The distribution according to gender was similar; but patients with influenza were younger than those suffering from COVID‐19(mean age 60.36 SD 17.28 vs. 61.88 SD 17.91; P = 0.601). In terms of underlying chronic diseases, the frequency was 84.3% in the COVID‐19 group and 72.7% in the influenza group. COVID‐19 patients had a longer duration of hospitalization (mean [SD], 9.51 days [8.47 days] vs. 7.33 days [8.82 days]; P = 0.003), and a more frequent need for invasive ventilation (80 [97.4%] vs. 20 [92.3]). Case fatality was also higher among this group compared to the latter (39 [47%] vs. 6 [27.3%], P = 0.01). Conclusion: This exploratory study suggests higher severity of COVID‐19 compared to seasonal influenza among SARI hospitalized patients even during the Omicron wave. Further research on higher sample sizes is required to confirm this conclusion. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

14. Evaluation of the influenza-like illness surveillance system in Tunisia, 2012–2015

Author

Yazidi, Rihab, Aissi, Wafa, Bouguerra, Hind, Nouira, Mariem, Kharroubi, Ghassen, Maazaoui, Latifa, Zorraga, Mokhtar, Abdeddaiem, Naima, Chlif, Sadok, El Moussi, Awatef, Ben Hadj Kacem, Mohamed Ali, Snoussi, Mohamed Ali, Ghawar, Wissem, Koubaa, Makram, Polansky, Lauren, McCarron, Margaret, Boussarsar, Mohamed, Menif, Khaled, Amine, Slim, Ben Khelil, Jalila, Ben Jemaa, Mounir, Bettaieb, Jihene, Bouafif Ben Alaya, Nissaf, and Ben Salah, Afif

Published
2019
Full Text
View/download PDF

15. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

Author

Baselga-Moreno, Víctor, Trushakova, Svetlana, McNeil, Shelly, Sominina, Anna, Nunes, Marta C., Draganescu, Anca, Unal, Serhat, Koul, Parvaiz, Kyncl, Jan, Zhang, Tao, Kuatbayeva, Ainagul, Ben-Salah, Afif, Burtseva, Elena, Puig-Barberà, Joan, Díez-Domingo, Javier, and for the Global Influenza Hospital Surveillance Network (GIHSN)

Published
2019
Full Text
View/download PDF

17. Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites

Author

Sghaier, Rabiaa M., primary, Benhnini, Fouad, additional, Guerfali, Fatma Z., additional, Attia, Hanène, additional, Bali, Aymen, additional, Zaatour, Amor, additional, Mkannez, Ghada, additional, Gharbi, Adel, additional, Belhaj-Hamida, Nabil, additional, Dridi, Hichem, additional, Ben-Salah, Afif, additional, Dellagi, Koussay, additional, and Laouini, Dhafer, additional

Published
2022
Full Text
View/download PDF

20. Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum

Author

Boussoffara Thouraya, Boubaker Mohamed Samir, Ben Ahmed Melika, Mokni Mourad, Guizani Ikram, Ben Salah Afif, and Louzir Hechmi

Subjects
Leishmania major, Leishmania infantum, lesion, cytokines, chemokines, Infectious and parasitic diseases, RC109-216
Abstract

Lesion features in cutaneous leishmaniasis (CL) depend on the infecting Leishmania species as well as on host immune reponse. In this study, we evaluated the histological and immunological differences between two forms of CL described in Tunisia: zoonotic cutaneous leishmaniasis (ZCL) caused by L. major and sporadic cutaneous leishmaniasis (SCL) caused by L. infantum. Histological analysis showed a mild to moderate infiltrate within ZCL lesions. In contrast, massive infiltration of the dermis was observed within SCL lesions. Contrary to ZCL, infiltrates within SCL lesions were organized and showed granuloma composed of macrophages and lymphocytes. In addition, immunohistochemical analysis showed a predominance of CD4+ T cells within both CL forms. Furthermore, expression of interferon-γ, interleukin (IL)-10, IL-8, IL-13 and monocyte chemotactic protein (MCP)-1 was evaluated using real-time quantitative polymerase chain reaction (RT-qPCR). MCP-1 and IL-10 were expressed at comparable levels in ZCL and SCL lesions. Interestingly, IL-8 mRNA levels were significantly higher in ZCL lesions compared to SCL lesions, but interferon-γ was significantly higher in SCL lesions than in ZCL lesions.

Published
2019
Full Text
View/download PDF

21. Evaluation of the Utility of Online Objective Structured Clinical Examination Conducted During the COVID-19 Pandemic

Author

Arekat, Mona, primary, Shehata, Mohamed Hany, additional, Deifalla, Abdelhalim, additional, Al-Ansari, Ahmed, additional, Kumar, Archana, additional, Alsenbesy, Mohamed, additional, Alshenawi, Hamdi, additional, El-Agroudy, Amgad, additional, Husni, Mariwan, additional, Rizk, Diaa, additional, Elamin, Abdelaziz, additional, Ben Salah, Afif, additional, and Atwa, Hani, additional

Published
2022
Full Text
View/download PDF

22. Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia

Author

Dhaouadi, Sonia, primary, Kharroubi, Ghassen, additional, Cherif, Amal, additional, Cherif, Ines, additional, Bouguerra, Hind, additional, Bouabid, Leila, additional, Najar, Nourhene, additional, Gharbi, Adel, additional, Ben Salah, Afif, additional, Bouafif ép Ben Alaya, Nissaf, additional, and Bettaieb, Jihene, additional

Published
2022
Full Text
View/download PDF

24. Intra-Specific Diversity of Leishmania major Isolates: A Key Determinant of Tunisian Zoonotic Cutaneous Leishmaniasis Clinical Polymorphism

Author

Attia, Hanene, primary, Sghaier, Manel, additional, Bali, Aymen, additional, Guerfali, Fatma, additional, Chlif, Sadok, additional, Atri, Chiraz, additional, Belhaj-Hamida, Nabil, additional, Zaatour, Amor, additional, Gharbi, Adel, additional, Ben-Salah, Afif, additional, Dellagi, Koussay, additional, and Laouini, Dhafer, additional

Published
2022
Full Text
View/download PDF

25. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

Author

Eropkin, M., Fadeev, A., Andrew, M., Ambrose, A., Mukasheva, E., Merkulova, L., Kruzhkova, I., Krasnoslobotsev, K., Kolobukhina, L., Kisteneva, L., Garina, E., Schwarz-Chavarri, G., Llorente-Nieto, P., Tortajada-Girbes, M., Fernandez-Dopazo, J., Generalova, L., Go, A., Golovacheva, E., Gonchar, V., Komissarov, A., Konovalova, N., Kuvarzina, S., Levanyuk, T., Lobova, T., Osidak, L., Roldan-Aguado, M., Mollar Maseres, J., Carballido-Fernandez, M., Adriana-Magos, E., Lopez-Labrador, X., Menif, K., Ozkaya-Parlakay, A., Tezer, H., Gulhan, B., Pisareva, M., Boukthir, A., Chlif, S., Rozhkova, E., Dellagi, M. K., Gharbi, A., Louzir, H., Yazidi, R., Zid, W., Laguna, A., Perez-Bao, J., Reyes, N., Coulibaly, D., Sanchez-Catalan, M. J., Mira-Iglesias, A., Martin-Navarro, M., Guglieri-Lopez, B., Garcia Esteban, S., Escribano-Lopez, B., Diez-Domingo, Javier, Puig-Barbera, Joan, Burtseva, Elena, Ben-Salah, Afif, Kuatbayeva, Ainagul, Sintsova, K., Sirotkina, Z., Smorodintseva, E., Koubaa, M., Zhang, Tao, Kyncl, Jan, Koul, Parvaiz, ÜNAL, SERHAT, Draganescu, Anca, Nunes, Marta C., Sominina, Anna, McNeil, Shelly, Ben Jeema, M., Trushakova, Svetlana, Baselga-Moreno, Victor, Ben Khelil, J., Amine, S., Gaukhar, N., Pitigoi, D., MacKinnon-Cameron, D., Nichols-Evans, M., Ye, P., Afanasieva, O., Afanasieva, A., Demina, S., Dondurei, E., Sukhovetskaya, V., Tamila, M., Voloshuk, L., Yanina, M., Zarishnyuk, P., Madhi, S. A., Arama, V., Florea, D., Luminos, M., Otelea, D., Sandulescu, O., Vlaicu, O., ElSherif, M., Aykac, K., Bosi, T. Bagci, Bilgin, E., Durusu, M., Kara, A., Ozisik, L., Basaranoglu, S. Tanir, Demirdag, TUĞBA, Tunccan, ÖZLEM, Ozgen, O., Pan, J., Zheng, J., Yan, Y., Zhao, G., Zhang, F., Shan, W., Chen, K., Standerova, I., Rudova, T., Rohacova, H., Herrmanova, K., Dvorska, D., Sebestova, H., Prochazkova, J., Mandakova, Z., Kralova, R., Jirincova, H., Havlickova, M., Bali, N., Yusuf, R., Soumya, Soumya, Mir, H., Khan, M., Ali, S., Hernandez, A., Moreno-Espinosa, S., Gamino-Arroyo, A. E., de la Rosa-Zamboni, D., Vidal-Vazquez, R. P., Ramirez-Hinojosa, J. P., Jimenez-Escobar, I., Dolores Dominguez-Viveros, W., de Colsa Ranero, A., Ruiz-Palacios, G. M., Guerrero Almeida, M. L., Galindo Fraga, A., Ciblak, M. Akcay, Tulek, N., Ozsoy, M., and Stolyarov, K.

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Influenza vaccine, Epidemiology, 030209 endocrinology & metabolism, Logistic regression, Global Health, 03 medical and health sciences, 0302 clinical medicine, Influenza A Virus, H1N1 Subtype, Pregnancy, Internal medicine, Influenza, Human, medicine, Humans, 030212 general & internal medicine, Risk factor, Child, Aged, Aged, 80 and over, Vaccine effectiveness, Surveillance, business.industry, Influenza A Virus, H3N2 Subtype, lcsh:Public aspects of medicine, Vaccination, Public Health, Environmental and Occupational Health, lcsh:RA1-1270, Odds ratio, Middle Aged, medicine.disease, Hospitalization, Influenza Vaccines, Child, Preschool, Female, Seasons, Biostatistics, business, Influenza virus, Sentinel Surveillance, Research Article
Abstract

Background The Global Influenza Hospital Surveillance Network (GIHSN) aims to determine the burden of severe influenza disease and Influenza Vaccine Effectiveness (IVE). This is a prospective, active surveillance and hospital-based epidemiological study to collect epidemiological data in the GIHSN. In the 2016–2017 influenza season, 15 sites in 14 countries participated in the GIHSN, although the analyses could not be performed in 2 sites. A common core protocol was used in order to make results comparable. Here we present the results of the GIHSN 2016–2017 influenza season. Methods A RT-PCR test was performed to all patients that accomplished the requirements detailed on a common core protocol. Patients admitted were included in the study after signing the informed consent, if they were residents, not institutionalised, not discharged in the previous 30 days from other hospitalisation with symptoms onset within the 7 days prior to admission. Patients 5 years old or more must also complied the Influenza-Like Illness definition. A test negative-design was implemented to perform IVE analysis. IVE was estimated using a logistic regression model, with the formula IVE = (1-aOR) × 100, where aOR is the adjusted Odds Ratio comparing cases and controls. Results Among 21,967 screened patients, 10,140 (46.16%) were included, as they accomplished the inclusion criteria, and tested, and therefore 11,827 (53.84%) patients were excluded. Around 60% of all patients included with laboratory results were recruited at 3 sites. The predominant strain was A(H3N2), detected in 63.6% of the cases (1840 patients), followed by B/Victoria, in 21.3% of the cases (618 patients). There were 2895 influenza positive patients (28.6% of the included patients). A(H1N1)pdm09 strain was mainly found in Mexico. IVE could only be performed in 6 sites separately. Overall IVE was 27.24 (95% CI 15.62–37.27. Vaccination seemed to confer better protection against influenza B and in people 2–4 years, or 85 years old or older. The aOR for hospitalized and testing positive for influenza was 3.02 (95% CI 1.59–5.76) comparing pregnant with non-pregnant women. Conclusions Vaccination prevented around 1 in 4 hospitalisations with influenza. Sparse numbers didn’t allow estimating IVE in all sites separately. Pregnancy was found a risk factor for influenza, having 3 times more risk of being admitted with influenza for pregnant women. Electronic supplementary material The online version of this article (10.1186/s12889-019-6713-5) contains supplementary material, which is available to authorized users.

Published
2019

28. Liste des collaborateurs

Author

Abdelhak, Sonia, primary, Aractingi, Sélim, additional, Aubin, François, additional, Ben Salah, Afif, additional, Boubaker, Sémir, additional, Carsuzaà, Francis, additional, Johan, Chanal, additional, Chosidow, Olivier, additional, Couppié, Pierre, additional, Crickx, Béatrice, additional, Georges-Yves, De Carsalade, additional, Delaunay, Pascal, additional, Del Giuduce, Pascal, additional, Desruelles, François, additional, Descamps, Vincent, additional, Develoux, Michel, additional, Giao, Do-pham, additional, Doutre, Marie-Sylvie, additional, Ducournau, Corinne, additional, Ducroux, Émilie, additional, Dupin, Nicolas, additional, Dalenda, El euch, additional, Lara, El hayderi, additional, Euvrard, Sylvie, additional, Farhi, David, additional, Ferneiny, Marie, additional, Ferrier-rembert, Audrey, additional, Feuilhade, De chauvin Martine, additional, Guyot, Alexis, additional, Hubiche, Thomas, additional, Lebbé, Céleste, additional, Lenormand, Cédric, additional, Levy, Eve, additional, Lipsker, Dan, additional, Lortholary, Olivier, additional, Mahé, Antoine, additional, Martins gomes, Ciro, additional, Maubec, Ève, additional, Mebazaa, Amel, additional, Merklen-djafri, Carine, additional, Mokni, Mourad, additional, Morand, Jean-Jacques, additional, Mougin, Christiane, additional, Nikkels, Arjen, additional, Pagès, Cécile, additional, Parize, Perrine, additional, Peyrefitte, Christophe, additional, Piérard, Gérald, additional, Piérard-franchimont, Claudine, additional, Poirier, Jean-Paul, additional, Pradinaud, Roger, additional, Prétet, Jean-Luc, additional, Roux, Jennifer, additional, Rybojad, Michel, additional, Soutou, Boutros, additional, Trojjet, Sondes, additional, and Vilmer, Catherine, additional

Published
2014
Full Text
View/download PDF

29. Psycho-social impacts, experiences and perspectives of patients with Cutaneous Leishmaniasis regarding treatment options and case management: An exploratory qualitative study in Tunisia

Author

Boukthir, Aicha, primary, Bettaieb, Jihene, additional, Erber, Astrid C., additional, Bouguerra, Hind, additional, Mallekh, Rym, additional, Naouar, Ikbel, additional, Gharbi, Adel, additional, Alghamdi, Manal, additional, Plugge, Emma, additional, Olliaro, Piero, additional, and Ben Salah, Afif, additional

Published
2020
Full Text
View/download PDF

31. Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis

Author

Ben Salah, Afif, Ben Messaoud, Nathalie, Guedri, Evelyn, Zaatour, Amor, Ben Alaya, Nissaf, Bettaieb, Jihene, Gharbi, Adel, Hamida, Nabil Belhadj, Boukthir, Aicha, Chlif, Sadok, Abdelhamid, Kidar, El Ahmadi, Zaher, Louzir, Hechmi, Mokni, Mourad, Morizot, Gloria, Buffet, Pierre, Smith, Philip L., Kopydlowski, Karen M., Kreishman-Deitrick, Mara, Smith, Kirsten S., Nielsen, Carl J., Ullman, Diane R., Norwood, Jeanne A., Thorne, George D., McCarthy, William F., Adams, Ryan C., Rice, Robert M., Tang, Douglas, Berman, Jonathan, Ransom, Janet, Magill, Alan J., and Grogl, Max

Published
2013
Full Text
View/download PDF

32. A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease

Author

Bettaieb, Jihène, primary, Toumi, Amine, additional, Ghawar, Wissem, additional, Chlif, Sadok, additional, Nouira, Mariem, additional, Belhaj-Hamida, Nabil, additional, Gharbi, Adel, additional, Ben-Alaya, Nissaf, additional, Laouini, Dhafer, additional, Louzir, Hechmi, additional, Dellagi, Koussay, additional, and Ben Salah, Afif, additional

Published
2020
Full Text
View/download PDF

33. Applying the moving epidemic method to determine influenza epidemic and intensity thresholds using influenza‐like illness surveillance data 2009‐2018 in Tunisia

Author

Bouguerra, Hind, primary, Boutouria, Elyes, additional, Zorraga, Mokhtar, additional, Cherif, Amal, additional, Yazidi, Rihab, additional, Abdeddaiem, Naima, additional, Maazaoui, Latifa, additional, ElMoussi, Awatef, additional, Abid, Salma, additional, Amine, Slim, additional, Bouabid, Leila, additional, Bougatef, Souha, additional, Kouni Chahed, Mohamed, additional, Ben Salah, Afif, additional, Bettaieb, Jihene, additional, and Bouafif Ben Alaya, Nissaf, additional

Published
2020
Full Text
View/download PDF

34. Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study

Author

Erber, Astrid C., primary, Arana, Byron, additional, Ben Salah, Afif, additional, Bennis, Issam, additional, Boukthir, Aicha, additional, Castro Noriega, María del Mar, additional, Cissé, Mamoudou, additional, Cota, Gláucia Fernandes, additional, Handjani, Farhad, additional, López-Carvajal, Liliana, additional, Marsh, Kevin, additional, Medina, Dalila Martínez, additional, Plugge, Emma, additional, Lang, Trudie, additional, and Olliaro, Piero, additional

Published
2020
Full Text
View/download PDF

35. Additional file 1: of Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

Author

Baselga-Moreno, Víctor, Trushakova, Svetlana, McNeil, Shelly, Sominina, Anna, Nunes, Marta, Draganescu, Anca, Unal, Serhat, Parvaiz Koul, Kyncl, Jan, Zhang, Tao, Kuatbayeva, Ainagul, Ben-Salah, Afif, Burtseva, Elena, Puig-Barberà, Joan, and Díez-Domingo, Javier

Abstract

Complementary Table S1. (DOCX 142 kb)

Published
2019
Full Text
View/download PDF

36. Seroprevalence of hepatitis A virus infection in Central‐West of Tunisia.

Author

Ayouni, Kaouther, Kharroubi, Ghassen, Mallekh, Rym, Hammami, Walid, Marouani, Ridha, Mhamdi, Moncef, Ben Salah, Afif, Triki, Henda, and Bettaieb, Jihène

Subjects
HEPATITIS viruses, HEPATITIS A virus, VIRUS diseases, VIRAL hepatitis, SEROPREVALENCE
Abstract

Hepatitis A infections still represent a major global health concern. During the past years, a transition pattern of the hepatitis A epidemiology was noted in many parts of the world. In Tunisia, there is not a recent survey on age‐specific hepatitis A virus seroprevalence. This study aimed to investigate the seroprevalence of hepatitis A virus infection in Central‐West Tunisia, representative of regions with lowest socioeconomic level in the country, before vaccine implementation. Sera obtained from the blood samples of subjects were screened for the detection of hepatitis A virus. The seroprevalence was evaluated by detection of total antibodies to hepatitis A virus using commercially available immunoassay kits. A total of 1379 subjects, aged 5–75 years (mean age: 29.0 ± 17.3 years) were studied. The global anti‐hepatitis A virus seroplevalence was 84.7% (95% confidence interval: [82.6–86.5]). A higher hepatitis A virus seroprevalence was showed in subjects aged 10–14 years compared to those aged less than 10 years (50.0% vs. 31.0%). In subjects aged 20–29 years, a rapid increase in the hepatitis A virus prevalence was noted; it reached 97.0%. The seroprevalence of anti‐hepatitis A virus differed by zone of residence (81.1% in rural area vs. 72.4% in urban area, p =.005) and increased significantly with lower level of education (p =.019). There was no statistical significant seroprevalence difference between male and female: 84.2% versus 85.2%, respectively. Our study confirm the transition pattern of the hepatitis A virus endemicity in Tunisia from high to intermediate and provide an evaluation of the hepatitis A virus epidemiological situation before vaccine implementation. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

40. An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol

Author

Erber, Astrid Christine, primary, Arana, Byron, additional, Bennis, Issam, additional, Ben Salah, Afif, additional, Boukthir, Aicha, additional, Castro Noriega, Maria del Mar, additional, Cissé, Mamoudou, additional, Cota, Gláucia Fernandes, additional, Handjani, Farhad, additional, Kebede, Mairie Guizaw, additional, Lang, Trudie, additional, López Carvajal, Liliana, additional, Marsh, Kevin, additional, Martinez Medina, Dalila, additional, Plugge, Emma, additional, and Olliaro, Piero, additional

Published
2018
Full Text
View/download PDF

42. First detection of Leishmania DNA in Psammomys obesus and Psammomys vexillaris : Their potential involvement in the epidemiology of leishmaniasis in Tunisia

Author

Ben Othman, Souad, primary, Ghawar, Wissem, additional, Chaouch, Melek, additional, Ayari, Chiraz, additional, Chemkhi, Jomaa, additional, Cancino-Faure, Beatriz, additional, Tomás-Pérez, Miriam, additional, Alcover, Maria Magdalena, additional, Riera, Cristina, additional, Ben Salah, Afif, additional, Fisa, Roser, additional, Ben Ismail, Riadh, additional, and Ben Abderrazak, Souha, additional

Published
2018
Full Text
View/download PDF

43. Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation

Author

Olliaro, Piero, primary, Grogl, Max, additional, Boni, Marina, additional, Carvalho, Edgar M., additional, Chebli, Houda, additional, Cisse, Mamoudou, additional, Diro, Ermias, additional, Fernandes Cota, Gláucia, additional, Erber, Astrid C., additional, Gadisa, Endalamaw, additional, Handjani, Farhad, additional, Khamesipour, Ali, additional, Llanos-Cuentas, Alejandro, additional, López Carvajal, Liliana, additional, Grout, Lise, additional, Lmimouni, Badre Eddine, additional, Mokni, Mourad, additional, Nahzat, Mohammad Sami, additional, Ben Salah, Afif, additional, Ozbel, Yusuf, additional, Pascale, Juan Miguel, additional, Rizzo Molina, Nidia, additional, Rode, Joelle, additional, Romero, Gustavo, additional, Ruiz-Postigo, José Antonio, additional, Gore Saravia, Nancy, additional, Soto, Jaime, additional, Uzun, Soner, additional, Mashayekhi, Vahid, additional, Vélez, Ivan Dario, additional, Vogt, Florian, additional, Zerpa, Olga, additional, and Arana, Byron, additional

Published
2018
Full Text
View/download PDF

44. Blood Meal Analysis of Phlebotomine Sandflies (Diptera: Psychodidae: Phlebotominae) for Leishmania spp. Identification and Vertebrate Blood Origin, Central Tunisia, 2015–2016

Author

Jaouadi, Kaouther, primary, Ben Salah, Afif, additional, Gonzalez, Jean-Paul, additional, Bennour, Amira, additional, Bettaieb, Jihene, additional, Ghawar, Wissem, additional, Salem, Sadok, additional, Khabouchi, Neila, additional, Rjeibi, Mohamed Ridha, additional, and Diouani, Mohamed Fethi, additional

Published
2018
Full Text
View/download PDF

47. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients

Author

Kaynar, Leylagül, Yildirim, Cuma, PANTOJA, Joao, Rocha, Ana, SCHRAMM, Edgar, TIMI, Jorge, STAIKOV, Ivan, BENOV, Haralambi, MIRAZCHIJSKI, Boyko, STATELOV, Evgenii, STOYKOVA, Antoaneta, TODOROV, Radostin, DENNIS, Rodolfo, DURA, Freddy Rafael Mendez, RESTREPO, Hector, ROA, Jairo H., VILLADIEGO, Juan, MALY, Jaroslav, BRABEC, Tomas, GUMULEC, Jaromir, JOCHYMEK, Roman, KELLNEROVA, Ivana, SKARKOVA, Jindra, SLEZAK, Premysl, VIT, Patrik, GOBRAN, Hadi, EL HADDAD, Alaa, RIZK-ALLAH, Mounir, BERGMANN, Jean Francois, ABINADER, Marid, KHOUDIR, Falah Abou, BOYER, Jean-Francois, BRUN, Natacha, CANET, Bernard, COLLARD, Catherine, CORDIER, Christophe, DURROUX, Claire, EMMERICH, Joseph, FRIOCOURT, Patrick, ANDERSON, Frederick A., CHERFI, Lyes, AMMOUR, Dehbia, BOURENANE, Razika, GRAINAT, Nadia, MAAROUF, Abderahmane, SISSAOUI, Abdelhak, GALLUS, Alexander, AYYAR, Venkatraman, CRIMMINS, Denis, GAN, Eng, MCRAE, Simon, SELDON, Michael, SINGH, Bhuwan, MOULA, Kaniz, NAWAZ, Taimor, NAZIMUDDIN, Khwaja, RAHMAN, Saiyeedur, SARKER, Shyamal, BRANDAO, Carlos, COSTA, Jose, MACEDO, Alex, MARINO, Roberto, MENEZES, Paulo, Bergmann, Jean-Francois, Cohen, Alexander T., Tapson, Victor F., Goldhaber, Samuel Z., Kakkar, Ajay K., Deslandes, Bruno, MOUMEN, Abdelrhani, PHILIPPE, Pierre, PROTIN, Yves, QUERE, Isabelle, RIZCALLAH, Marie-Jeanne, BENSCH, Kristina, BENSMANN, Klaus, Dropmann, Axl, Gerold, Dieter, Gussmann, Andreas, Kube, Lutz, Kuster, Stefan, Leupolz, Werner, Neuhaus, Thomas, Nobel, Wolfgang, Pfiel, Sascha, Pleger, Eberhard, Trautmann, Harald, Voigt, Ingo, Liapis, Christos, Antoniadis, Pavlos, Arvanitis, Dimitrios, Bakatsglos, Spyridon, Christakis, Christos, Gerassimidis, Thomas, Kostakis, Alkiviadis, Losonczy, Hajna, Hajna, Bela, Gyani, Eva, Jojart, Istvan, Kecskes, Gabor, Lakatos, Jozsef, Ledniczki, Istvan, Mayer, Klara, Nyuzo, Balint, Zeher, Margit, Agnihotri, Vinod, Balraj, A., Chakraborty, Amiya, Desai, Sanjay, Elangovan, Antony, Goswami, Partha, Rupert, Emmanuel, Toraskar, Kedar, Venkatesh, Kakollu, Gaine, Sean, Costello, Richard, Liston, Richard, Zubieta, Ricardo Martinez, Fematt, Flor Mario Avila, Esponda, Juan Alejandro Baeza, Benitez Maldonado, Daniel R., Serrano, Maricela Escarela, Montalvo, Carlos Lavalle, Marquez, Santa Lopez, Sanchez, Alejandro Quesada, Diaz, Santiago Ramirez, Serrano, Alejandro Tovar, de la Vega, Maria Isabel Villa, Faridi, Salman, Javaid, Mansur, Khan, Farrukh, Malik, Asif Zafar, Sadiq, Muzafaruddin, Musial, Jacek, Biedziuk, Bartlomiej, Gellert, Ryszard, Kosiniau-Kamysz, Andrzey, Kuta, Marcin, Prajs, Zozislav, Sell, Marek, Tadeusz, Kalbarczyk, Witkiewicz, Wojciech, Wysota, Janusz, Franca, Ana, Abreu, Rui, Cartucho, Daniel, Lohmann, Corinna, Moreira, Pedro, Paulino, Aida, Reis, Abilio, Rojao de Morais, Maria Luisa, Tribolet de Abreu, Tiago, Tulbure, Dan, Andrei, Muresan, Christian, Pricop, Ciurea, Mircea, Enachescu, Mihaela, Gostian, Ovidiu, Grintescu, Ioana Marina, Mimor, Ovidiu, Natalia, Hagau, Puiac, Claudiu, Valerica, Stan, Sulimov, Vitalyi Andreevich, Belentsov, Sergey, Eliseeva, Ekaterina, Fridman, Irina, Kazantchian, Perch, Mashtacov, Boris, Redkin, Alexander, Rodoman, Grigory, Shershnev, Vladislav, Zhidkov, Konstantin, Gaspar, Ludovit, Benova, Katarina, Duris, Tibor, Fecik, Juraj, Hajas, Jan, Herman, Oto, Lehotsky, Jan, Macek, Vladimir, Pradova, Viera, Carrascosa, Miguel, Luque, Rafael Cuenca, del Val Gil, Jose, Diaz de Souza, Pedro, Enfedaque, Muriel Alvaro, Gonzalo, Francesc Epelde, Sanchez, Florentino Garcia, Garcia, Guil, Lopez, Luciano, Rodriguez, Jose Antonio Nieto, Mateo Paredes, Ramon, Ramos Rodriguez, Jose Luis, Cantero, Alberto Ruiz, Lorenzo, Pedro Ruiz, Legarre, Angel Luis Samperiz, Clavo Sanchez, Antonio, Bernad, Reina Valle, Vela Moreno, Jeronimo Ramon, Doerffler, Janine, Beer, Jurg, Brunner, Brigitte, Chopard, Pierre, Fischer, Joseph, Ludwig, Christian, Rime, Francis, Salomon, Franco, Ulrich, Munch, Angchaisuksiri, Pantep, Chetanachan, Mariam, Chuamuangphan, Nonlawan, Insiripong, Somchai, Nawarawong, Weerasak, Ben Salah, Afif, Houman, Mohamed Habib, Mohamed, Mnif, Samir, Kammoun, Smiti-Khanfir, Monia, Zouheir, Jerbi, Ongen, Gul, Altintas, Faik, Cirak, Ali Kadri, Demirtas, Nazmi, Erden, Faruk, Guven, Hulya, Halezeroglu, Semih, Karaoglan, Halim, Tereci, Hikmet, Wilmott, Rosalind, Cohen, Alexander, Calvey, Thomas, Cohen, Angela, Gallegos, Nick, Gaminara, Elizabeth, James, Anthony, Jeffreys, Mike, Jowett, Nigel, Keaney, Niall, Kesteven, Patrick, Khan, Zafar, Mallick, Abhiram, Marval, Paul, Parapia, L., Picozzi, Natalie, Praveen, Bandipalyam, Satchi, Gnanam, Valerio, David, Tapson, Victor, Anderson, Fred, Baker, Gennfer, Beaver, Richard, Becker, William, Beckett, Cynthia, Borchardt, Carla, Briggs, Michael, Bruckman, Joseph, Buck, Lisa, Chausow, Alan, Christopulos, Danielle, Cica, Paula, Cody, Jean, Condit, Bruce, Cronin, Sherill, Huang, Wei, BENTAKOUK, Cherif, SIDDIQUI, F. M., OIGMAN, Wille, PAIVA, Marcelo, TANDEITNIK, Liane, BORISOV, Stefan Dimitrov, LALOV, Anton, POSTADZIYAN, Arman, Cysyk, Barbara, Driggers, Steven, Ellis, Paula, Elvenia, Jaeda, Feinbloom, David, Feldman, Mark, Fischer, Marian, Froehlich, James, Frost, Christopher, Galster, Ruth, Geldmeier, Richard, George, Joyce, Glielmi, Vincent, Goodwin, James, Gottlieb, Anita, Gray, Bruce, Harrington, Darrell, Henry, Edwina, Hill, David, Hutchinson, Melissa, Johnson, Juanita, Johnson, Roberta, Kapre, Sheela, Kedzie, Robyn, Kowaloff, Harvey, Krodel, John, Lehman, James, Marshall, Ingeborg, McDaniels, Mary, Middleton, Robert, Mitchell, Phillip, Nelson, Carrie, Netherland, Susan, Ogden, Maureen, Packard, Keith, Poole, Lorie, Radford, Martha, Rathbun, Suman, Roberts, Cathy, Robinson, Margaret, Rollins, David, Rubinate, Donna, Schmidt, Cheryl, Scott, Julia, Slone, Betty, Spyropoulos, Alex, Subramanian, Seshan, Sullivan, Jacqueline, Timmerman, Carman, Vizzard, Carolyn, Wheeler, Connie, White, Diane, White, Nancy, Wright, Joyce, Young, Dereck, SOKOLOV, Krassimir, STEFANOV, Chavdar, TADZHER, Sheri, POSADA, Jose Alfredo, KVASNICKA, Jan, PENKA, Miroslav, VOJTISEK, Petr, EL RAHMAN, Alaa Mahmaud Aba, GORGY, George Sobhy, SHOLKAMY, Sherif, GENAY, Patrick, IBOUANGA, Florent, PLANCHON, Pierre, ZOTZ, Rainer, Kortmann, Bernd, Wolf, Stefan, Domjan, Gyula, Pinjala, Ramakrishna, Connaughton, John, Perez, Fernando Elias Garcia, Yusaf-Shah, Muhammad, Klonowski, Wlodzimierz, Campello, Maria da Gloria Cabral, Constantin, Palivan, Dubrovnaya, Nina, Barta, Peter, Arcelus, Juan, Lobo-Beristain, Jose Luis, Cardenas, Maria Jose Soto, Peter, Jurg, Ghedira, Habib, Dokucu, Ali, Mackie, Peter, Antonacci, Anthony, Caushaj, Philip, Diefendorf, Anne, Gaffey, Joseph, Hernandez, Cecilia, Marney, Terri, Pieske, Marlys, Shutt, Sandra, and Whitehead, Alva

Subjects
Adult, medicine.medical_specialty, Cross-sectional study, Population, Hemorrhage, Risk Assessment, Fibrinolytic Agents, Residence Characteristics, Risk Factors, Intensive care, Odds Ratio, medicine, Humans, Registries, cardiovascular diseases, Healthcare Disparities, Risk factor, education, Intensive care medicine, Aged, Cardiopulmonary disease, Aged, 80 and over, Inpatients, education.field_of_study, business.industry, Contraindications, Age Factors, Venous Thromboembolism, Hematology, Odds ratio, Middle Aged, medicine.disease, Hospitalization, Venous thrombosis, Cross-Sectional Studies, Logistic Models, Treatment Outcome, Health Care Surveys, Practice Guidelines as Topic, Guideline Adherence, Risk assessment, business
Abstract

SummaryLimited data are available regarding the risk for venous thromboembolism (VTE) and VTE prophylaxis use in hospitalised medically ill patients. We analysed data from the global ENDORSE survey to evaluate VTE risk and prophylaxis use in this population according to diagnosis, baseline characteristics, and country. Data on patient characteristics, VTE risk, and prophylaxis use were abstracted from hospital charts. VTE risk and prophylaxis use were evaluated according to the 2004 American College of Chest Physicians (ACCP) guidelines. Multivariable analysis was performed to identify factors associated with use of ACCP-recommended prophylaxis. Data were evaluated for 37,356 hospitalised medical patients across 32 countries. VTE risk varied according to medical diagnosis, from 31.2% of patients with gastrointestinal/hepatobiliary diseases to 100% of patients with acute heart failure, active non-infectious respiratory disease, or pulmonary infection (global rate, 41.5%). Among those at risk for VTE, ACCP-recommended prophylaxis was used in 24.4% haemorrhagic stroke patients and 40–45% of cardiopulmonary disease patients (global rate, 39.5%). Large differences in prophylaxis use were observed among countries. Markers of disease severity, including central venous catheters, mechanical ventilation, and admission to intensive care units, were strongly associated with use of ACCP-recommended prophylaxis. In conclusion, VTE risk varies according to medical diagnosis. Less than 40% of at-risk hospitalised medical patients receive ACCP-recommended prophylaxis. Prophylaxis use appears to be associated with disease severity rather than medical diagnosis. These data support the necessity to improve implementation of available guidelines for evaluating VTE risk and providing prophylaxis to hospitalised medical patients.

Published
2010

50. State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans

Author

MERS-CoV Research Group, Who, Ben Salah, Afif, Fontanet, Arnaud, Manuguerra, Jean-Claude, Van Der Werf, Sylvie, Mounts, Anthony W., World Health Organisation (WHO), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Cellule d'Intervention Biologique d'Urgence - Laboratory for Urgent Response to Biological Threats (CIBU), Institut Pasteur [Paris] (IP), Génétique Moléculaire des Virus Respiratoires, Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Global Influenza Programme, Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM), Institut Pasteur [Paris], and Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Institut Pasteur [Paris]

Subjects
0303 health sciences, medicine.medical_specialty, business.industry, Middle East respiratory syndrome coronavirus, Research, Medicine (miscellaneous), medicine.disease_cause, Virology, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, medicine, 030212 general & internal medicine, Intensive care medicine, business, 030304 developmental biology
Abstract

International audience; BACKGROUND: Between September 2012 and 22 October 2013, 144 laboratory-confirmed and 17 probable MERS-CoV cases from nine countries were notified to WHO.METHODS: We summarize what is known about the epidemiology, virology, phylogeny and emergence of MERS-CoV to inform public health policies.RESULTS: The median age of patients (n=161) was 50 years (range 14 months to 94 years), 64.5% were male and 63.4% experienced severe respiratory disease. 76.0% of patients were reported to have ≥1 underlying medical condition and fatal cases, compared to recovered or asymptomatic cases were more likely to have an underlying condition (86.8% vs. 42.4%, p0 is

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results